Fluid Resuscitation in Septic Shock Patients With BMI Elevation
- Conditions
- Septic ShockObesitySepsis
- Interventions
- Procedure: Ideal Body Weight DosingProcedure: Adjusted Body Weight DosingProcedure: Actual Body Weight Dosing
- Registration Number
- NCT04759989
- Lead Sponsor
- Wake Forest University Health Sciences
- Brief Summary
To explore the safety and feasibility of alternative fluid resuscitation strategies in obese patients with septic shock.
- Detailed Description
Early, goal-directed therapy with timely achievement of hemodynamic stability has been shown to clearly improve outcomes in patients with septic shock. Although Surviving Sepsis Campaign guidelines recommend a weight-based approach to initial fluid resuscitation (i.e. 30ml/kg),1 at present, there are no robust data to support whether dosing based on actual body weight or an alternative correction formula (ideal body weight, adjusted body weight) is superior.
FRISSBE is a prospective, randomized, three-arm parallel-group pilot trial of alternative resuscitation strategies for obese patients with septic shock, looking at feasibility and safety of different weight-based approaches. Subject treatment assignment will not be blinded. Data will be collected and analyzed on an intent-to-treat basis. The study will enroll 60 subjects, with 20 subjects per treatment arm. Subjects will be randomized to receive one of three weight-based initial fluid resuscitation strategies - 30cc/kg ideal body weight (IBW), 30cc/kg adjusted body weight (AdjBW), or 30cc/kg actual body weight (ABW).
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 7
-
18 years of age or older
-
BMI > 30
-
suspected infection, and either:
- hypotension (a systolic blood pressure < 90mmHg) or
- blood lactate concentration > 4mmol/L
- Pregnant
- Primary diagnosis of acute cerebral vascular event
- Acute coronary syndrome
- Acute pulmonary edema
- Status asthmaticus
- Major cardiac arrhythmia
- Active gastrointestinal hemorrhage
- Seizures
- Drug overdose
- Burns or trauma
- Requirement for immediate surgery
- CD4<50/mm3
- Do-not-resuscitate order status
- Transferred from another hospital
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 30cc/kg ideal body weight (IBW) Ideal Body Weight Dosing 30cc/kg intravenous fluids based on the patients calculated ideal body weight will be administered when randomized to this arm Using Devine's formula. (men: 50kg + 2.3kg \* (height(in) - 60); women: 45.5kg + 2.3kg \* (height(in) - 60) 30cc/kg adjusted body weight (AdjBW) Adjusted Body Weight Dosing 30cc/kg intravenous fluids based on the patients calculated adjusted body weight will be administered when randomized to this arm Calculated by the following formula: AdjBW = IBW + 0.4(ABW - IBW). 30cc/kg actual body weight (ABW) Actual Body Weight Dosing 30cc/kg intravenous fluids based on the patients actual body weight will be administered when randomized to this arm Patients will receive an initial fluid bolus of 30 cc/kg of actual body weight
- Primary Outcome Measures
Name Time Method Safety-time to hemodynamic stability 72 hours time from randomization to map \>65 without use of vasopressors and no lactate \>2
Feasibility1: fluid target 3 hours percentage of of patients with actual volume received within 10% of target fluid volume.
Safety-vasopressors 24 hours proportion of patients requiring vasopressor administration
Safety-ventilation 24 hours Proportion of patients requiring invasive or noninvasive mechanical ventilation
- Secondary Outcome Measures
Name Time Method feasibility2: recruitment rate study duration proportion of patients enrolled out of patients screened to randomized through completion of study, an average of 1 year
Exploratory: in-hospital all cause mortality 28 days Proportion of patient in each group who experience death due to any cause during hospitalization up to 28 days
Exploratory: ICU length of stay 28 days number of consecutive midnights in ICU
feasibility3: time to randomization 3 hours median time from screening to randomization
Exploratory: hospital length of stay 28 days number of midnights spent in hospital up to 28 days
Trial Locations
- Locations (1)
Carolinas Medical Center
🇺🇸Charlotte, North Carolina, United States